Literature DB >> 6402

Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

I M Katz, W A Hubbard, A J Getson, A L Gould.   

Abstract

Timolol ophthalmic solutions 0.5 per cent, 1.0 per cent, and 1.5 per cent lowered intraocular pressures significantly in normal human volunteers. Maximum lowering of the intraocular pressures was reached at two hours with the 0.5 per cent solution of timolol and at one hour with the 1.0 per cent and 1.5 per cent timolol ophthalmic solutions. The effect lasted the full seven hours of observations. No objective or subjective evidence of ocular irritation could be attributed to the drug. A single dose of timolol applied topically to the eyes of normal human volunteers had no effect on pupillary size, visual acuity, blood pressure, or pulse rate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6402

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  35 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.

Authors:  M R al-Sereiti; R L Coakes; D P O'Sullivan; P Turner
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

3.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

4.  The treatment of glaucoma: role of beta-blocking agents.

Authors:  W P Boger
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

5.  A study of the effects of four concentrations of D-timolol, 0.25% L-timolol, and placebo on intraocular pressure on patients with raised intraocular pressure.

Authors:  K B Mills; N J Jacobs; R Vogel
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

6.  Ultrastructural changes of the rabbit corneal epithelium and endothelium after Timoptic treatment.

Authors:  G S Liu; P K Basu; G E Trope
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

7.  Epinephrine distribution after topical administration to phakic and aphakic eyes.

Authors:  S G Kramer
Journal:  Trans Am Ophthalmol Soc       Date:  1980

8.  Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.

Authors:  K Wettrell; K Wilke; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

9.  Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.

Authors:  F E Ros; C L Dake; N J Nagelkerke; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-06-19

10.  Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.

Authors:  F E Ros; C L Dake; L Offerhaus; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.